Financhill
Back

Regenxbio Quote, Financials, Valuation and Earnings

Sell
44

RGNX
Regenxbio

Last Price:
16.01
Seasonality Move:
7.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Regenxbio Price Quote

$16.01
-0.22 (-1.36%)
(Updated: May 16, 2024 at 4:40 PM ET)

Regenxbio Key Stats

Sell
44
Regenxbio (RGNX) is a Sell

Day range:
$16.01 - $16.85
52-week range:
$11.83 - $28.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.29
P/B ratio:
2.05%

Volume:
400.8K
Avg. volume:
414.2K
1-year change:
-25.24%
Market cap:
$799.4M
Revenue:
$90.2M
EPS:
$-5.87

How Much Does Regenxbio Make?

  • How Much Are Regenxbio's Sales Annually?
    RGNX Revenues are $90.2M
  • How Much Profit Does Regenxbio's Make A Year?
    RGNX net income is -$263.5M

Is Regenxbio Growing As A Company?

  • What Is Regenxbio's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.18%
  • What Is Regenxbio's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Regenxbio Stock Price Performance

  • Did Regenxbio Stock Go Up Last Month?
    Regenxbio share price went down by -9.93% last month
  • Did RGNX's Share Price Rise Over The Last Year?
    RGNX share price fell by -25.24% over the past 1 year

What Is Regenxbio 52-Week High & Low?

  • What Is Regenxbio’s 52-Week High Share Price?
    Regenxbio has traded as high as $28.80 over the past 52 weeks
  • What Is Regenxbio’s 52-Week Low Share Price?
    Regenxbio has traded as low as $11.83 over the past 52 weeks

Regenxbio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Regenxbio?

  • How Much Debt Does Regenxbio Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Regenxbio Have?
    Cash and short term investments quarterly total is $338.7M
  • What Is Regenxbio’s Book Value Per Share?
    Book value per share is 7.97

Is Regenxbio Cash Flow Positive?

  • What Is RGNX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$192.9M
  • What Is Regenxbio’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $94.8M
  • What Is Regenxbio’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $141M

Regenxbio Return On Invested Capital

  • Is Management Doing A Good Job?
    RGNX return on invested capital is -67.17%
  • What Is Regenxbio Return On Assets?
    ROA measures how assets are converting to revenues and is -39.81%
  • What Is RGNX Return On Equity?
    ROE is a measure of profitability and is -67.17%

Regenxbio Earnings Date & Stock Price

  • What Is Regenxbio's Stock Price Today?
    A single share of RGNX can be purchased today for 16.23
  • What Is Regenxbio’s Stock Symbol?
    Regenxbio trades on the nasdaq under the ticker symbol: RGNX
  • When Is Regenxbio’s Next Earnings Date?
    The next quarterly earnings date for Regenxbio is scheduled on August 2, 2024
  • When Is RGNX's next ex-dividend date?
    Regenxbio's next ex-dividend date is May 16, 2024
  • How To Buy Regenxbio Stock?
    You can buy Regenxbio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Regenxbio Competitors

  • Who Are Regenxbio's Competitors?
    Below is a list of companies who compete with Regenxbio or are related in some way:
    • AbbVie Inc (ABBV)
    • Catalyst Pharmaceuticals Inc (CPRX)
    • Edgewise Therapeutics Inc (EWTX)
    • PTC Therapeutics Inc (PTCT)
    • Sarepta Therapeutics Inc (SRPT)

Regenxbio Dividend Yield

Data Unavailable

Regenxbio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -6.24%
Revenue: -18.37% -33.59%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 39.08
Upside from Last Price: 140.81%

Major Shareholders

  • How many RGNX shares are owned by institutional investors?
    58.1M RGNX shares are owned by institutional investors
  • How many RGNX shares are owned by insiders?
    1.2M RGNX shares are owned by insiders